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56 The Journal of Thoracic and Cardiobjective: There is little information available on the results of reconstructive
rterial surgery for Takayasu’s arteritis in children. This study evaluates midterm to
ong-term outcome after surgical, as well as interventional, procedures.
ethods: From 1984 through 2004, 10 children (5 boys and 5 girls; age, 12.7  2.6
ears) with Takayasu’s arteritis were referred to our center. Baseline cardiovascular
ssessment included contrast angiography (n  4), magnetic resonance imaging–
ngiography (n  3), and combined contrast angiography plus magnetic resonance
maging–angiography (n  3). Two patients had disease confined to the thoracic
orta, 4 had disease confined to the abdominal aorta, and 4 had combined thoraco-
bdominal aortic disease. Steno-occlusive lesions were predominant in 92% of
ases. Seven patients were maintained on steroid therapy throughout the follow-up
eriod. Eight children underwent complex surgical procedures, 1 patient had balloon
ilatation of the renal and mesenteric arteries, and 1 patient had combined vascular
urgery with percutaneous transluminal angioplasty. Overall, 24 grafts (polytetra-
uoroethylene, Dacron grafts, and cryopreserved homografts) were implanted in
arious locations.
esults: There were no perioperative deaths. Arterial hypertension regressed in all
atients, and cardiac function normalized in all 4 patients with dilative cardiomy-
pathy. Over a 20-year period, 1 patient presented with sudden death and 2 showed
onfatal disease progression, one of whom required surgical reintervention. The
cclusion rate was higher in Dacron grafts.
onclusions: Our study shows that despite the extent and severity of vascular
esions, children with Takayasu’s arteritis could benefit from reconstructive surgery,
ith low mortality, morbidity, and satisfactory long-term results.
akayasu’s arteritis (TA) is a chronic idiopathic inflammatory disease affect-
ing primarily the aorta and its main branches but can also involve the
coronary, carotid, pulmonary, and renal arteries.1 TA constitutes the third
ost common form of vasculitis in the pediatric population worldwide.2
Steroids or cytotoxic drugs have been shown to improve the systemic inflam-
atory symptoms associated with the active phase of the disease, although opera-
ions and percutaneous transluminal angioplasty (PTA) procedures have been used
o treat complications arising from steno-occlusive or aneurysmal lesions in the
hronic stage. There are, however, very few reports on surgical and interventional
echniques or the evaluation of results over time in the pediatric population.3,4
This article describes our surgical and percutaneous approach in 10 pediatric
atients with TA over the past 20 years and evaluates midterm and long-term
utcome.
vascular Surgery ● September 2006
M
P
F
t
p
b
c
i
o
0
t
a
I
r
p
h
d
r
l
c
p
D
A
e
t
(
d
M
c
w
a
a
(
d
m
l
g
(
s
t
d
a
s
t
t
p
P
I
C
o
b
a
o
v
S
R
W
m
n
u
1
R
I
E
r
m
a
v
O
r
a
o
a
i
f
t
i
O
M
2
(
a
m
p
l
i
c
p
L
Kalangos et al Surgery for Congenital Heart Disease
CH
Dethods
atients
rom 1984 through 2004, 10 patients were referred to our institu-
ion with the diagnosis of TA. There were 5 male and 5 female
atients aged 12.7 2.6 years (range, 8-15 years). All patients had
een given diagnoses by using the criteria proposed by Sharma and
olleagues.1 Seven patients met the major criteria, and the remain-
ng 3 met the minor criteria. The time interval between the onset
f symptoms and diagnosis ranged from 0.5 to 4 years (mean, 2 
.7 years). A common clinical finding was that of arterial hyper-
ension, which was present in 8 patients, with significant renal
rtery stenosis in 6 of them, 5 being refractory to medication.
ncreased C-reactive protein (CRP) levels (5 mg/L) and eryth-
ocyte sedimentation rates (ESRs; 50 mm/h) were present in 7
atients. Indications for surgical intervention, PTA, or both were
igh-grade asymptomatic carotid stenosis, limb ischemia or clau-
ication, severe hypertension, mesenteric ischemia, and aortic
egurgitation with an associated ascending aortic aneurysm of
arger than 5 cm. Table 1 shows patient demographics and relevant
linical and laboratory findings. This retrospective study was ap-
roved by the human studies committee at our institution.
iagnostic Investigations
ll patients underwent extensive cardiovascular assessment
ither by means of transthoracic echocardiography (TTE), con-
rast angiography (CA), and/or magnetic resonance imaging
MRI)-angiography preoperatively and after intervention. CA was
one in 4 patients, MRI-angiography in 3, and combined CA plus
RI-angiography in the remaining 3. Applying the angiographic
riteria reported by Hata and associates,5 2 (20%) of our patients
ere classified as type II, 2 (20%) as type III, 4 (40%) as type IV,
nd the remaining 2 as type V (Figure 1). Overall, CA, MRI-
ngiography, or both detected 36 significant vascular lesions: 33
92%) lesions were stenotic or occlusive, and 3 lesions were
ilative or aneurysmal. Stenotic lesions were estimated as mild,
oderate, or severe on the basis of the angiographic degree of
uminal narrowing of less than 30%, between 30% and 80%, and
reater than 80%, respectively.
Four children had TTE findings of dilative cardiomyopathy
patients 2, 5, 6, and 9) with significantly reduced left ventricular
hortening fraction (LVSF). In 1 patient (patient 7) severe hyper-
Abbreviations and Acronyms
CA  contrast angiography
CRP  C-reactive protein
ESR  erythrocyte sedimentation rate
LRA  left renal artery
LVSF left ventricular shortening fraction
MRI magnetic resonance imaging
PTA  percutaneous transluminal angioplasty
PTFE  polytetrafluoroethylene
SMA  superior mesenteric artery
TA  Takayasu’s arteritis
TTE  transthoracic echocardiographyrophic obstructive cardiomyopathy was responsible for low car- p
The Journal of Thoraciciac output on admission. Patient 8 had important dilation of the
scending aorta with severe resulting aortic regurgitation. In 9 patients
igns of left ventricular hypertrophy were present on a 12-lead elec-
rocardiogram, and 3 patients showed severe cardiomegaly (cardio-
horacic index, 0.65) on chest radiography. Table 2 summarizes all
reoperative investigations performed in our series.
reoperative and Postoperative Corticotherapy
n 7 patients (patients 1, 3-7, and 10) in whom increased preoperative
RP levels of greater than 5 mg/L, an ESR of greater than 50 mm/h,
r both was observed, prednisone (0.7-1.0 mg/kg1/d1) was begun
efore intervention and then gradually tapered to 0.5 mg/kg1/d1
nd maintained at 0.25 mg/kg1/d1 once clinical remission was
btained throughout the perioperative and follow-up periods to pre-
ent recrudescent inflammation.
tatistics
esults are expressed as mean values  standard deviations. The
ilcoxon signed-rank test was used to compare matched nonpara-
etric values, the Mann-Whitney U test was used to compare
onmatched nonparametric values, and the Fisher exact test was
sed to compare nonmatched parametric values (SPSS, Version
1.5).
esults
nterventions
ight children underwent reconstructive surgery. Patient 4
equired PTA of the right renal artery and the superior
esenteric artery (SMA), and patient 6 required a combined
pproach of vascular surgery and PTA. The type of inter-
ention and the graft material used are listed in Table 3.
verall, 24 grafts were implanted in various sites: 9 polytet-
afluoroethylene (PTFE) grafts, 8 cryopreserved homografts,
nd 7 Dacron grafts. Figures 2 and 3 demonstrate examples
f preoperative and postoperative angiographic and MRI-
ngiographic findings in patients 7 and 9. During surgical
ntervention, a sample of diseased vessel wall was resected
or histology. All specimens showed granulomatous panar-
eritis with identifiable giant cells and lymphoplasmocytic
nfiltration.
utcome
ean hospital stay was 14  2 days, with a range of 10 to
5 days. There were no perioperative deaths, but 1 patient
patient 8) died suddenly of an unknown cause 2 years after
n aortic root replacement with a cryopreserved aortic ho-
ograft. Unfortunately, postmortem examination was not
erformed in his country of origin. All patients received a
ong-term aspirin regimen.
Clinically, all patients were significantly improved after
ntervention (all patients in New York Heart Association
lass I or II at 3 months). TTE at 6 months showed im-
roved systolic cardiac function, with an overall increase in
VSF from an average of 25.5% 13.3% (range, 6%-47%)
reoperatively to 32.8%  6.0% (range, 25%-45%) at 6
and Cardiovascular Surgery ● Volume 132, Number 3 657
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Donths after intervention (P .015). At this time, there was
lso a significant reduction in left ventricular end-diastolic
iameter (from 4.6  0.9 cm to 3.9  0.7 cm, P  .005).
mportantly, of the 4 patients with dilative cardiomyopathy,
he LVSF normalized in 2 (patients 2 and 6: preoperatively
rom 9% to 14% to 32% and 28%, respectively), and sig-
ificant improvement was observed in the other 2 patients
patients 5 and 9: preoperatively from 17% and 6% to 27%
nd 25%, respectively) at 2 years. Patient 7, who had under-
one an associated septal myotomy for severe hypertrophic
bstructive cardiomyopathy at the time of the initial operation,
ad residual left ventricular outflow tract obstruction with a
eak gradient of 30 mm Hg on the TTE at discharge. However,
ABLE 1. Preoperative patient characteristics
atient no. Age (y), sex NYHA class Laboratory
1 15, M I CRP 1, ESR 1
2 14, F III-IV Normal
3 12, M III CRP 1, ESR 1
4 8, M II CRP 1, ESR 1
5 14, F I CRP 1, ESR 1
6 9, F III CRP 1, ESR 1
7 14, M III CRP 1, ESR 1
8 15, M III Normal
9 14, F III, IV Normal
10 15, F II CRP 1, ESR 1
YHA, New York Heart Association; CRP, C-reactive protein (CRP 1, 
ressure; HOCM, hypertrophic obstructive cardiomyopathy.Figure 1. Classification of Takayasu’s arteritis a
58 The Journal of Thoracic and Cardiovascular Surgery ● Septeith a 1-year -blocking (propranolol) maintenance therapy,
he left ventricular hypertrophy regressed, and the residual
utflow tract obstruction disappeared.
After intervention, systemic arterial blood pressure con-
rol was more easily and reliably achieved in the 8 patients
ith abnormal preoperative values, although most required
t least one antihypertensive drug (patients 1, 2-4, 6, and 10)
r combined (-blocker plus angiotensin-converting en-
yme inhibitor) antihypertensive drug therapy (patients 9
nd 5) during the first postoperative year. After this period,
he antihypertensive medication maintenance had been
ompletely stopped. All patients, except the first one, re-
ained normotensive throughout the entire follow-up pe-
Relevant clinical findings
h BP (210/150 mm Hg)
h BP (160/90 mm Hg), dilative cardiomyopathy
h BP (190/112 mm Hg), abdominal pain
h BP (157/87 mm Hg), abdominal pain
h BP (220/130 mm Hg), dilative cardiomyopathy
h BP (150/85 mm Hg), dilative cardiomyopathy
w BP (70/50 mm Hg), HOCM
spnea on effort (120/40 mm Hg)
h BP (177/127 mm Hg), abdominal pain, dilative cardiomyopathy
h BP (157/87 mm Hg), abdominal pain
L); ESR, erythrocyte sedimentation rate (ESR 1, 50 mm/h); BP, bloodHig
Hig
Hig
Hig
Hig
Hig
Lo
Dy
Hig
Hig
5 mg/nd distribution of the cases for each type.
mber 2006
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Diod. Therapy-resistant systemic hypertension redeveloped
n patient 1 because of progressive right renal artery steno-
is, which had only been mild in 1989. When the patient
eturned to our center in 2001 at the age of 27 years, this
enal artery had become completely occluded, and the atro-
hic kidney had to be removed.
All patients had follow-up assessments between 1 and 20
ears (mean, 12.3  5 years) after intervention. This included
iagnostic repeat studies of cardiovascular lesions by means of
A and MRI-angiography (6 CAs, 8 MRI-angiographies, and
MRIs, with subsequent CAs between 1 and 10 years
ostoperatively; 1 CA, 3 MRI-angiographies, and 1 MRI,
ith subsequent CAs between 10 and 20 years postopera-
ively; Figures 2-4). Table 3 summarizes the midterm and
ong-term postoperative outcome based on data from CA
nd MRI-angiography. Two patients required redo opera-
ions between the first and fifth postoperative years for
rogressive occlusion of the abdominal aorta, stenosis of
oth renal arteries, and occlusion of the SMA Dacron graft
t the proximal anastomosis in patient 1. This patient was
esistant to steroid therapy, and cytotoxic drug therapy
ould not be instigated because of difficulties in the man-
gement of these drugs in his country of origin. Patient 5
ad stenosis of the left renal artery (LRA) and aneurysmal
ilatation of the abdominal aortic homograft. Patient 6 un-
erwent redo PTA of the right renal artery after 5 years.
ABLE 2. Preoperative investigations
atient
o.
Echocardiography
ECG CTI SF (%) LVEDD (cm) Valve functi
1 LVH 0.47 33 4.4
2 LVH 0.69 9 5.8 MR 
TR 
3 LVH 0.51 30 4.0 AR
4 Normal 0.46 38 4.2
5 LVH 0.70 17 6.0 MR
AR 
6 LVH 0.72 14 6.1
7 LVH 0.50 47 3.2
8 LVH 0.59 32 4.4 AR
MR
9 LVH 0.53 6 4.2 MR 
TR 
AR 
10 LVH 0.45 29 4.0
CG, Electrocardiography; CTI, cardiothoracic index; SF, shortening fr
ypertrophy; CT, celiac trunk; SMA, superior mesenteric artery; LRA, left re
nd abdominal aorta; HA, hepatic artery; IA, iliac artery; RRA, right renal art
A, renal artery; Desc Ao, descending aorta; Asc Ao, ascending aorta; LCetween the first and fifth postoperative years, 2 of the 7 y
The Journal of Thoracicacron grafts developed significant stenosis (patient 1), and
of the 8 homografts developed lesions, with 1 aneurysmal
nd 1 stenotic lesion (patient 9). Histopathologic examina-
ion of the deteriorated homograft showed extensive
ransparietal fibrosis with increased neovessel formation
nd several fibrolipidic plaques, with no evidence of calci-
cation or acute inflammation.
One patient had significant stenosis at the distal anasto-
osis of the SMA Dacron graft (patient 2) between the sixth
nd tenth postoperative years and subsequently underwent
uccessful PTA.
One patient had reocclusion of the SMA Dacron graft
nd the right renal Dacron graft (patient 1) between the 11th
nd 20th postoperative years. The SMA had well-developed
ollateral circulation, but the right kidney was atrophic and
equired right nephrectomy.
The overall restenosis or graft occlusion rate was 18%
4/24 grafts) between the first and fifth postoperative years,
ecreasing to 5% (1/20 grafts) between the 6th and 10th
ostoperative years and to 10% (2/19 grafts) between the
1th and 20th postoperative years. The stenosis or aneurys-
al formation rate with cryopreserved homografts was 25%
2/8 grafts) over a period of 11 years (between 1993 and
004), whereas a stenosis and occlusion rate of 70% (5/7
rafts) was observed in Dacron grafts over a period of 20
Diagnosed lesions
Stenosis (n) Occlusion (n)
Dilatation or
aneurysm (n)
— CT, SMA, LRA (3) —
TA Ao, SMA, LRA, HA,
both IAs (6)
RRA, RFA (2) TA Ao, CT (2)
Abd Ao, both IAs,
both RAs (4)
— —
SMA, RRA (2) — —
Abd Ao, both RAs (3) — —
Desc Ao, RRA (2) — —
Asc Ao, aortic arch
and supra-aortic
vessels (5)
— —
— — Asc Ao (1)
Desc Ao, RRA (2) Abd Ao, LRA (2) —
TA Ao, LCA (2) — —
; LVEDD, left ventricular end-diastolic diameter; LVH, left ventricular
rtery; MR, mitral regurgitation; TR, tricuspid regurgitation; TA Ao, thoracic
FA, right femoral artery; AR, aortic regurgitation; Abd Ao, abdominal aorta;
ft carotid artery.ons
action
nal a
ery; Rears. None of the 9 PTFE grafts presented significant
and Cardiovascular Surgery ● Volume 132, Number 3 659
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Dtenosis or occlusion over the 20-year period. The mean
ollow-up period for Dacron grafts was 18  2.2 years and
as statistically longer than for the PTFE grafts (9.9  7.3
ears, P .01) and homografts (7.1 2.5 years, P .001).
ABLE 3. Interventions and postoperative outcome
atient
o. Date Intervention
Postoperative
treatment
1 1984 Ao-LRA (8 mm), SMA (6 mm),
HA (6 mm) bypasses with
Dacron grafts
Prednisolone
Aspirin
Re
2 1986 Asc Ao–bilateral iliac
arteries bypass with
Dacron graft (10-8 mm) 
reimplantation of SMA 
graft-both RAs (6 mm)
bypasses with PTFE grafts
Aspirin Mi
3 1989 Asc Ao–bilateral iliac
arteries bypass with
Dacron graft (10-8 mm) 
Ao-LRA (8 mm)  Ao-SMA
(6 mm) bypasses with
PTFE grafts
Prednisolone
Aspirin
No
4 1992 PTA of SMA and RRA Prednisolone
Aspirin
No
5 1993 Replacement of Abd Ao with
PTFE graft (14 mm) 
graft-both RAs bypasses
(6 mm) with homograft
Prednisolone
Aspirin
Mi
6 1995 Ao isthmus–Abd Ao bypass
with PTFE graft (14 mm) 
PTA of RRA
Prednisolone
Aspirin
Re
7 1997 Replacement of Asc Ao and
aortic arch with 2
homografts (19 mm; septal
myotomy)
Prednisolone
Aspirin
No
8 1998 Aortic root replacement with
homograft
Aspirin Die
9 1999 Replacement of Abd Ao with
homograft (16 mm) 
graft-both RAs bypasses
with homografts (6 mm)
Aspirin Re
10 2003 Asc Ao–bilateral iliac
arteries bypass with PTFE
graft (10-8 mm)  Asc
Ao–LCA bypass with PTFE
graft (7 mm)
Prednisolone
Aspirin
Mi
o, Aorta; LRA, left renal artery; SMA, superior mesenteric artery; HA, hep
sc Ao, ascending aorta; PTFE, polytetrafluoroethylene; PTA, percutaneouhe freedom from occlusion/restenosis was statistically sig- n
60 The Journal of Thoracic and Cardiovascular Surgery ● Septeificant in favor of the PTFE grafts (100%) compared with
he Dacron grafts (58%) at 7 years (P .005). However, the
reedom from occlusion/restenosis between PTFE grafts
nd homografts (75%) at 7 years was not statistically sig-
Postoperative outcome
1-5 y 6-10 y 11-20 y
ment of Abd Ao
reimplantation of
revious SMA
and both RAs
ses with Dacron
after 3 y
Mild stenosis of the distal
anastomosis of RRA
bypass
Occlusion of the
RRA and SMA
bypasses;
right
nephrectomy
after 17 years
nosis of the
anastomosis of
artery after 5 y
PTA of the distal
anastomosis of SMA 
mild stenosis of the
distal anastomosis of
both RAs after 10 y
Moderate
stenosis of
the distal
anastomosis
of both RAs
osis Mild stenosis of the distal
anastomosis of the
iliac arteries, LRA and
SMA after 8 y
Moderate
stenosis of
the distal
anastomosis
of LRA and
SMA
osis Mild stenosis of RRA and
SMA after 7 y
Mild stenosis of
RRA and SMA
after 12 y
nosis of the
anastomosis of
t 5 y
Mild stenosis of the distal
anastomosis of both
RAs after 10 y
Moderate
stenosis of
the distal
anastomosis
of both RAs
of RRA after 5 y Mild stenosis of the distal
anastomosis of RRA
after 9 y
y after operation
own cause)
cement of the
o (Dacron) and
ass (PTFE) to
fter 5 y
nosis of the
anastomosis of
nd right iliac
after 1 y
artery; Abd Ao, abdominal aorta; RA, renal artery; RRA, right renal artery;
nsluminal angioplasty; LCA, left carotid artery.place
with
the p
graft
bypas
grafts
ld ste
distal
SMA
sten
sten
ld ste
distal
LRA a
-PTA
rmal
d 2
(unkn
repla
Abd A
rebyp
LRA a
ld ste
distal
LCA a
artery
aticificant (Figure 5).
mber 2006
Kalangos et al Surgery for Congenital Heart DiseaseFigure 2. Preoperative magnetic resonance imaging (patient 7) showing severe obstructive hypertrophic cardio-
myopathy of the left ventricle (A) and thickening of the aortic wall (B). C, Preoperative angiography showing
narrowing of the ascending aorta and the aortic arch and stenosis of all cervical branches. D, Postoperative
magnetic resonance imaging 2 years after homograft replacement of the ascending aorta, aortic arch, and proximal
segments of the supraortic trunks, with no evidence of homograft calcifications or degeneration.CH
DFigure 3. A, Preoperative magnetic resonance imaging-angiography (patient 9) showing complete occlusion of a
long segment of the infrarenal aorta and perfusion of the distal aorta through Riolan’s arcade and the inferior
mesenteric artery. B, Postoperative magnetic resonance imaging-angiography at 6 months showing patency
of the abdominal aortic homograft and the 2 renal artery homografts without signs of restenosis or graft
degeneration. C, Postoperative magnetic resonance imaging-angiography at 5 years showing aneurysmal
dilatation of the abdominal aortic homograft with diffuse stenosis of the left renal homograft artery.
The Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 3 661
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DDuring follow-up, both patients (patients 4 and 6) who
nitially underwent PTA interventions experienced resteno-
is, one being a severe case estimated at 90% that was
uccessfully dilated (case 6) 3 years after initial PTA and
he other being a mild case (30%) not requiring any inter-
ention as of yet.
iscussion
A is a rare disease in most western countries. In the early
tages of the disease, prominent symptoms can be nonspe-
ific, and vasculitis frequently remains unrecognized. Thus
iagnosis is usually delayed once ischemic events become
anifest in the late steno-occlusive phase.6,7 The delay in
iagnosis was 2 years in our pediatric population, which is
ike that reported by Hoffman,8 who also showed that this
elay was shorter (5 months) in adults.
CA has been the gold standard diagnostic approach for
valuation of vascular lesions in the past. At our institution,
RI-angiography has progressively replaced CA over time
n the diagnosis and evaluation of the arterial system in
atients with TA, especially because it avoids the use of
adiation and important quantity of nephrotoxic contrast
yes in the pediatric population. MRI techniques allow for
he measurement of both arterial wall thickness and edema,
ndings that correlate with clinical symptoms of acute vas-
ulitis.9 However, MRI-angiography has some limitations
igure 4. Magnetic resonance imaging (A) and magnetic reso-
ance imaging–angiography (B; patient 6) showing a patent poly-
etrafluoroethylene bypass graft from the thoracic to abdominal
orta (Ao) at 2 postoperative years.n detecting lesions in the digestive and renal arteries and in m
62 The Journal of Thoracic and Cardiovascular Surgery ● Septehe supra-aortic trunks,10 so that 3 of our patients required
dditional CA for adequate topographic information on the
xtension and severity of the arterial lesions. Computed
omography has not been used as a diagnostic tool at our
nstitution, even though there are recent reports showing
xcellent results with this technique, which might someday
ival CA as the standard method of diagnosis.11
In our series 92% of the observed lesions consisted of
ascular stenoses of varying degrees of severity. Dilative
esions have been reported to occur in 2% to 27% of cases
f TA,12 and our series had an 8% incidence. Mild aortic
nsufficiency is not uncommon, with a reported incidence of
% to 16%,13,14 being 30% in our series. Moreover, an
neurysmal ascending aorta with severe aortic insufficiency
as the predominant indication for surgical intervention in
atient 8.
Nine of our 10 patients preferentially underwent vascular
econstructive surgery for lesions too extensive to be ap-
roached by means of interventional catheter procedures
lone and too advanced and severe to be treated pharmaco-
ogically. Thanks to improvements in anesthesia, surgical
echniques, and postoperative care, even high-risk patients,
uch as those with low LVSF or dilative cardiomyopathy,
hich constituted 40% in our series, can now be approached
urgically, with excellent immediate, midterm, and long-
erm results and low morbidity and improved quality of life,
s confirmed by our data.
A wide variety of graft materials was used in our pa-
ients, with the choice of Dacron or PTFE being surgeon
elated up until 1993. Since 1993, the preferred graft mate-
ial for children became the cryopreserved arterial ho-
igure 5. Freedom from occlusion/restenosis over the follow-up
eriod. PTFE, Polytetrafluoroethylene.ografts when available. Eight (62%) of the 13 grafts used
mber 2006
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Detween 1993 and 2004 were indeed homografts in an effort
o improve the long-term graft patency of the small arteries
nd to avoid long-term anticoagulation therapy in aortic
alve replacement, which is particularly important in devel-
ping countries, in which periodic international normalized
atio controls are uncertain. Two homografts degenerated in
child not started on steroids postoperatively, thus requir-
ng a redo operation. However, there was no observed
tructural deterioration of homograft in the remaining pa-
ients, all of whom did receive postoperative steroid treat-
ent, as evidenced by repeat MRI-angiographies over an
1-year period. This might be explained by the immuno-
uppressive effect of steroids attenuating the immune reac-
ion against homografts,15 which has been speculated to
ontribute to early homograft deterioration in children. Al-
hough graft material of choice remains unclear because of
he limited number of cases, our results with Dacron grafts
70% occlusion rate in this series) correspond to those
eported earlier by Kerr,16 who also found Dacron grafts to
e less favorable conduits in these patients. In our series all
ignificant restenoses occurred at the distal anastomotic
ites between the Dacron grafts and native arteries, except in
atient 9, in whom restenosis of the homograft conduit to
he LRA was diffuse, affecting the entire length of the ho-
ograft. The main reason for restenoses at the distal anasto-
oses is that the bypass of the affected vessels originated from
ither an implanted graft or uninvolved area of the aorta to a
oint with macroscopically unsuspected active disease, which
s often difficult to precisely assess during surgical interven-
ion, in addition to the inability to predict future involvement of
n otherwise normal-appearing segment.
Endovascular therapy is theoretically attractive for the
reatment of relatively short lesions amenable to PTA, stent-
ng, or both, with multiple case reports and series describing
pplications to the great vessels, aorta, and renal arter-
es.17-24 Despite a high initial success rate, restenosis of
essels having undergone angioplasty or stented vessels
ccurred between 25% and 60% of cases within 2
ears.17-24 Moreover, data describing long-term patency and
utcomes are lacking. This high rate of restenosis might be
ue to application of endovascular procedures at sites of
nsuspected active disease.
Congestive heart failure in children with TA might be
aused by long-standing systemic arterial hypertension and
xceptionally to severe aortic insufficiency. In our series 4
hildren presented with severe dilative cardiomyopathy
ith an LVSF of 17% or less, most likely caused by
ncreased afterload from severe reno-occlusive arterial hy-
ertension, as well as to extended thoracoabdominal or
bdominal aortic stenosis. After relief of renal obstruction
ither by means of surgical intervention (patients 2 and 5) or
atheter balloon dilatation (patient 6), systolic function nor-
alized completely in 2 patients, whereas it improved to
The Journal of Thoracicearly normal systolic function within the 6 first months
ostoperatively in the other 2 patients.
On the basis of previously published data, it is not clear
hy the 5-year mortality in children is higher than in adults
35% vs 3% to 7%, respectively).25,26 It has been speculated
hat systemic inflammation progresses, particularly in the
ediatric population, and that this might influence long-term
urvival.27 In 7 of our patients admitted with high preoper-
tive CRP and ESR values, prednisone was administrated
efore and maintained after surgical intervention to prevent
isease progression. Only one of these 7 patients was resis-
ant to prednisone and later had restenosis and subsequent
cclusion of his grafts over the follow-up period of 20 years.
n the other hand, of the remaining 3 patients with normal
reoperative CRP and ESR values who were therefore not
tarted on prednisone, the first had restenoses of the by-
assed vessels requiring PTA, the second died of an un-
nown cause 2 years after surgical intervention, and the
hird experienced homograft deterioration requiring a redo
peration at 5 years after surgical intervention. Neverthe-
ess, when compared with previous reports on survival rates
n children with TA, our series demonstrates better mid-
erm and long-term prognosis, even for particularly se-
erely affected children. We believe that this could be
elated to permanent remission induced by nonstop steroid
herapy. Moreover, lesions associated with TA can some-
imes heal with steroids alone. In our series the majority of
atients with a mild degree of stenoses remained stable with
orticotherapy.
onclusion
ur study shows that despite the extent and severity of
ascular lesions, all children with TA could be amenable to
econstructive procedures with low mortality and morbidity
isks and satisfactory midterm and long-term results. Per-
anent postoperative steroid therapy seems to play an im-
ortant role in the improvement of survival by preventing
he persistence of inflammation and progression of vascular
esions over time. Systolic cardiac function, which can be
everely impaired in some cases before intervention, might
ully recover within weeks to months after intervention. In
ur experience with steroid therapy, the restenosis rate
ppears to be lower for PTFE grafts and cryopreserved
omografts than for Dacron grafts. However, because the
isease can progress despite anti-inflammatory therapy, all
atients with TA undergoing operations require regular
ollow-up assessment (preferably with MRI-angiography)
f the aortic segments and interposed grafts to prevent the
onsequences of gradually impaired organ dysfunction.
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